{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T03:45:20Z","timestamp":1792986320889,"version":"4.5.0"},"reference-count":44,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T00:00:00Z","timestamp":1740528000000},"content-version":"unspecified","delay-in-days":25,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001922","name":"Efficacy and Mechanism Evaluation Programme","doi-asserted-by":"publisher","award":["NIHR131082"],"award-info":[{"award-number":["NIHR131082"]}],"id":[{"id":"10.13039\/501100001922","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2025,1,28]]},"published-print":{"date-parts":[[2025,2]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Oligodendroglioma (ODG) is a rare type of brain tumour, typically diagnosed in younger adults and associated with prolonged survival following treatment. The current standard of care is maximal safe debulking surgery, radiotherapy (RT) and adjuvant procarbazine, lomustine and vincristine (PCV) chemotherapy. Patients may experience long-term treatment-related toxicities, with RT linked to impairments of neurocognitive function (NCF) and health-related quality of life (HRQoL). With proton beam therapy (PBT), radiation dose falls off sharply beyond the target with reduced normal brain tissue radiation doses compared with photon RT. Therefore, PBT might result in reduced radiation-induced toxicity compared with photon RT.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>APPROACH is a multicentre open-label phase III randomised controlled trial of PBT versus photon RT in patients with ODG, investigating the impact of PBT on long-term NCF measured using the European Organisation for Research and Treatment of Cancer (EORTC) Core Clinical Trial Battery Composite (CTB COMP). The trial will randomise 246 participants from 18 to 25 UK RT sites, allocated 1:1 to receive PBT or photon RT, with PBT delivered at one of the two UK PBT centres. Participants with grade 2 and grade 3 ODG will receive 54 Gy in 30 fractions and 59.4 Gy in 33 fractions, respectively, followed by 6\u00d76-weekly cycles of PCV chemotherapy. The trial contains staged analyses, with an internal pilot for feasibility of recruitment at 12 months, early assessment of efficacy at 2 years, futility assessment and final primary endpoint comparison of NCF between arms at 5 years. Secondary endpoints include additional NCF, treatment compliance, acute and late toxicities, endocrinopathies, HRQoL, tumour response, progression-free survival and overall survival.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>Ethical approval was obtained from Newcastle North Tyneside REC (reference 22\/NE\/0232). Final trial results will be published in peer-reviewed journals and adhere to International Committee of Medical Journal Editors (ICMJE) guidelines.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>ISRCTN:13390479.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2024-097810","type":"journal-article","created":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T12:53:02Z","timestamp":1740574382000},"page":"e097810","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":11,"title":["APPROACH: Analysis of Proton versus Photon Radiotherapy in Oligodendroglioma and Assessment of Cognitive Health \u2013 study protocol paper for a phase III multicentre, open-label randomised controlled trial"],"prefix":"10.1136","volume":"15","clinical-trial-number":[{"clinical-trial-number":"nct03180502","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct03180502","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Finbar","family":"Slevin","sequence":"first","affiliation":[{"name":"Leeds Institute of Medical Research, University of Leeds, Leeds, UK"},{"name":"Leeds Cancer Centre, Leeds Teaching Hospitals NHS Trust, Leeds, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8758-7163","authenticated-orcid":false,"given":"Eleanor Mae","family":"Hudson","sequence":"additional","affiliation":[{"name":"Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florien W","family":"Boele","sequence":"additional","affiliation":[{"name":"Leeds Institute of Medical Research, University of Leeds, Leeds, UK"},{"name":"Leeds Institute of Health Sciences, University of Leeds, Leeds, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James R","family":"Powell","sequence":"additional","affiliation":[{"name":"Velindre University NHS Trust, Cardiff, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Noutch","sequence":"additional","affiliation":[{"name":"Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myfanwy","family":"Borland","sequence":"additional","affiliation":[{"name":"The Clatterbridge Cancer Centre NHS Foundation Trust, Liverpool, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7975-7537","authenticated-orcid":false,"given":"Sarah","family":"Brown","sequence":"additional","affiliation":[{"name":"Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Bruce","sequence":"additional","affiliation":[{"name":"The Clatterbridge Cancer Centre NHS Foundation Trust, Liverpool, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Bulbeck","sequence":"additional","affiliation":[{"name":"Brainstrust, Cowes, Isle of Wight, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil G","family":"Burnet","sequence":"additional","affiliation":[{"name":"Christie NHS Foundation Trust, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen Ching","family":"Chang","sequence":"additional","affiliation":[{"name":"University College London Hospitals NHS Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rovel","family":"Colaco","sequence":"additional","affiliation":[{"name":"Christie NHS Foundation Trust, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart","family":"Currie","sequence":"additional","affiliation":[{"name":"Department of Radiology, Leeds Teaching Hospitals NHS Trust, Leeds, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Egleston","sequence":"additional","affiliation":[{"name":"The Clatterbridge Cancer Centre NHS Foundation Trust, Liverpool, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi","family":"Fersht","sequence":"additional","affiliation":[{"name":"University College London Hospitals NHS Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Klein","sequence":"additional","affiliation":[{"name":"Medical Psychology, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Lilley","sequence":"additional","affiliation":[{"name":"Leeds Cancer Centre, Leeds Teaching Hospitals NHS Trust, Leeds, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Lowe","sequence":"additional","affiliation":[{"name":"Christie NHS Foundation Trust, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Miles","sequence":"additional","affiliation":[{"name":"Mount Vernon Hospital, Northwood, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert D","family":"Murray","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Leeds Teaching Hospitals NHS Trust, Leeds, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J","family":"O\u2019Hara","sequence":"additional","affiliation":[{"name":"St George\u2019s, Lincolnshire Partnership NHS Foundation Trust, Lincoln, Lincolnshire, UK"},{"name":"School of Health and Wellbeing, University of Glasgow, Glasgow, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Norris","sequence":"additional","affiliation":[{"name":"Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Parbutt","sequence":"additional","affiliation":[{"name":"Medicines Management and Pharmacy Services, Leeds Teaching Hospitals NHS Trust, Leeds, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Smith","sequence":"additional","affiliation":[{"name":"Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Smith","sequence":"additional","affiliation":[{"name":"Christie NHS Foundation Trust, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gillian A","family":"Whitfield","sequence":"additional","affiliation":[{"name":"Christie NHS Foundation Trust, Manchester, UK"},{"name":"Manchester Academic Health Science Centre, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Short","sequence":"additional","affiliation":[{"name":"Leeds Institute of Medical Research, University of Leeds, Leeds, UK"},{"name":"Leeds Cancer Centre, Leeds Teaching Hospitals NHS Trust, Leeds, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Murray","sequence":"additional","affiliation":[{"name":"Leeds Institute of Medical Research, University of Leeds, Leeds, UK"},{"name":"Leeds Cancer Centre, Leeds Teaching Hospitals NHS Trust, Leeds, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,2,26]]},"reference":[{"key":"2025121513174308000_15.2.e097810.1","unstructured":"Cancer Research UK . Oligodendroglioma. 2019. Available: https:\/\/www.cancerresearchuk.org\/about-cancer\/brain-tumours\/types\/oligodendroglioma"},{"key":"2025121513174308000_15.2.e097810.2","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noab106"},{"key":"2025121513174308000_15.2.e097810.3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1500925"},{"key":"2025121513174308000_15.2.e097810.4","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noac202"},{"key":"2025121513174308000_15.2.e097810.5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1402121"},{"key":"2025121513174308000_15.2.e097810.6","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.04.6078"},{"key":"2025121513174308000_15.2.e097810.7","doi-asserted-by":"crossref","first-page":"e315","DOI":"10.1016\/S1470-2045(17)30194-8","article-title":"European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas","volume":"18","author":"Weller","year":"2017","journal-title":"Lancet Oncol"},{"key":"2025121513174308000_15.2.e097810.8","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.43.2229"},{"key":"2025121513174308000_15.2.e097810.9","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(09)70204-2"},{"key":"2025121513174308000_15.2.e097810.10","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/S0140-6736(02)11398-5","article-title":"Effect of radiotherapy and other treatment-related factors on mid-term to long-term cognitive sequelae in low-grade gliomas: a comparative study","volume":"360","author":"Klein","year":"2002","journal-title":"The Lancet"},{"key":"2025121513174308000_15.2.e097810.11","article-title":"Long-term neurocognitive and other side effects of radiotherapy, with or without chemotherapy, for glioma","volume":"8","author":"Lawrie","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"2025121513174308000_15.2.e097810.12","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-020-03454-3"},{"key":"2025121513174308000_15.2.e097810.13","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.56.9079"},{"key":"2025121513174308000_15.2.e097810.14","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s00066-016-1005-9","article-title":"Dosimetric advantages of proton therapy over conventional radiotherapy with photons in young patients and adults with low-grade glioma","volume":"192","author":"Harrabi","year":"2016","journal-title":"Strahlenther Onkol"},{"key":"2025121513174308000_15.2.e097810.15","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s11060-015-1952-5","article-title":"Neurocognitive effects of proton radiation therapy in adults with low-grade glioma","volume":"126","author":"Sherman","year":"2016","journal-title":"J Neurooncol"},{"key":"2025121513174308000_15.2.e097810.16","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.29237"},{"key":"2025121513174308000_15.2.e097810.17","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.radonc.2019.04.027","article-title":"Long-term outcomes and late adverse effects of a prospective study on proton radiotherapy for patients with low-grade glioma","volume":"137","author":"Tabrizi","year":"2019","journal-title":"Radiother Oncol"},{"key":"2025121513174308000_15.2.e097810.18","first-page":"17","article-title":"Systematic review of methodology used in clinical studies evaluating the benefits of proton beam therapy","volume":"19","author":"Ofuya","year":"2019","journal-title":"Clin Transl Radiat Oncol"},{"key":"2025121513174308000_15.2.e097810.19","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.27.1932"},{"key":"2025121513174308000_15.2.e097810.20","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(11)70057-2"},{"key":"2025121513174308000_15.2.e097810.21","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(10)70294-1"},{"key":"2025121513174308000_15.2.e097810.22","unstructured":"Cohen J . Statistical Power Analysis for the Behavioral Sciences. 2nd edn. New York: Routledge, 1988."},{"key":"2025121513174308000_15.2.e097810.23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.radonc.2020.03.023","article-title":"Cognitive impairment following radiation to hippocampus and other brain structures in adults with primary brain tumours","volume":"148","author":"Haldbo-Classen","year":"2020","journal-title":"Radiother Oncol"},{"key":"2025121513174308000_15.2.e097810.24","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1186\/s13063-019-3578-y","article-title":"Progression criteria in trials with an internal pilot: an audit of publicly funded randomised controlled trials","volume":"20","author":"Herbert","year":"2019","journal-title":"Trials"},{"key":"2025121513174308000_15.2.e097810.25","unstructured":"US Department of Health and Human Services Food and Drug Administration . Multiple Endpoints in Clinical Trials Guidance for Industry. 2017."},{"key":"2025121513174308000_15.2.e097810.26","unstructured":"US Department of Health and Human Services Food and Drug Administration . Adaptive Design Clinical Trials for Drugs and Biologics Guidance for Industry. 2019."},{"key":"2025121513174308000_15.2.e097810.27","unstructured":"National Cancer Institute . Common toxicity criteria for adverse events (version 5.0). 2017. Available: https:\/\/ctep.cancer.gov\/protocoldevelopment\/electronic_applications\/ctc.htm#ctc_60"},{"key":"2025121513174308000_15.2.e097810.28","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1212\/WNL.0b013e318283bb0a","article-title":"Neuroanatomical target theory as a predictive model for radiation-induced cognitive decline","volume":"80","author":"Peiffer","year":"2013","journal-title":"Neurology (ECronicon)"},{"key":"2025121513174308000_15.2.e097810.29","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2020.103073","article-title":"Why brain radiation therapy should take account of the individual structural and functional connectivity: Toward an irradiation '\u00e0 la carte'","volume":"154","author":"Duffau","year":"2020","journal-title":"Crit Rev Oncol Hematol"},{"key":"2025121513174308000_15.2.e097810.30","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.radonc.2021.05.013","article-title":"Update of the EPTN atlas for CT- and MR-based contouring in Neuro-Oncology","volume":"160","author":"Eekers","year":"2021","journal-title":"Radiother Oncol"},{"key":"2025121513174308000_15.2.e097810.31","unstructured":"Gondi V , et al . Hippocampal Contouring: A Contouring Atlas for RTOG 0933. 2014. Available: https:\/\/rtog.org"},{"key":"2025121513174308000_15.2.e097810.32","unstructured":"Sobotta J , et al . Sobotta Atlas of Human Anatomy: Edited by R. Putz and R. Pabst with Assistance of Renate Putz. 13th edn. Philadelphia: Lippincott Williams & Wilkins, 2001."},{"key":"2025121513174308000_15.2.e097810.33","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.radonc.2013.10.035","article-title":"Recommendation for a contouring method and atlas of organs at risk in nasopharyngeal carcinoma patients receiving intensity-modulated radiotherapy","volume":"110","author":"Sun","year":"2014","journal-title":"Radiother Oncol"},{"key":"2025121513174308000_15.2.e097810.34","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2012.11.031"},{"key":"2025121513174308000_15.2.e097810.35","doi-asserted-by":"publisher","DOI":"10.1038\/nn1050"},{"key":"2025121513174308000_15.2.e097810.36","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s11060-019-03259-z","article-title":"Association between tumor location and neurocognitive functioning using tumor localization maps","volume":"144","author":"Habets","year":"2019","journal-title":"J Neurooncol"},{"key":"2025121513174308000_15.2.e097810.37","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.clon.2019.09.049","article-title":"Patient Involvement in the Design of a Randomised Trial of Proton Beam Radiotherapy Versus Standard Radiotherapy for Good Prognosis Glioma","volume":"32","author":"Powell","year":"2020","journal-title":"Clin Oncol"},{"key":"2025121513174308000_15.2.e097810.38","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20200247","article-title":"Heavy charged particle beam therapy and related new radiotherapy technologies: The clinical potential, physics and technical developments required to deliver benefit for patients with cancer","volume":"93","author":"Kirkby","year":"2020","journal-title":"Br J Radiol"},{"key":"2025121513174308000_15.2.e097810.39","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.clon.2019.09.052","article-title":"TORPEdO \u2013 A Phase III Trial of Intensity-modulated Proton Beam Therapy Versus Intensity-modulated Radiotherapy for Multi-toxicity Reduction in Oropharyngeal Cancer","volume":"32","author":"Price","year":"2020","journal-title":"Clin Oncol"},{"key":"2025121513174308000_15.2.e097810.40","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.clon.2018.02.031","article-title":"Proton Beam Therapy \u2013 the Challenges of Delivering High-quality Evidence of Clinical Benefit","volume":"30","author":"Amos","year":"2018","journal-title":"Clin Oncol"},{"key":"2025121513174308000_15.2.e097810.41","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.clon.2022.11.017","article-title":"Developing a National Infrastructure for Proton Beam Therapy Trials","volume":"35","author":"Rieu","year":"2023","journal-title":"Clin Oncol"},{"key":"2025121513174308000_15.2.e097810.42","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noz130"},{"key":"2025121513174308000_15.2.e097810.43","doi-asserted-by":"publisher","DOI":"10.1016\/j.clon.2021.09.010"},{"key":"2025121513174308000_15.2.e097810.44","doi-asserted-by":"publisher","DOI":"10.1016\/j.acn.2006.05.007"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2024-097810","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T21:17:51Z","timestamp":1765833471000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2024-097810"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":44,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,2,26]]},"published-print":{"date-parts":[[2025,2]]}},"alternative-id":["10.1136\/bmjopen-2024-097810"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2024-097810","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2]]}}}